Medtechs’ View Of UK Brexit Deal: More Certainty, But Still No Detail
Executive Summary
COVID-19 is of no lesser importance to the UK medtech industry, but attention is now refocusing on Brexit, future regulation and trade deals.
You may also be interested in...
UK Health Care At The Crossroads As Medtechs Watch For Bill, Brexit And NHS Change
The UK health care system is keen to reshape in light of the lessons learned from COVID-19, but it comes at a time when Brexit trade issues and device regulatory system changes are already muddying the waters.
EU MDR: Swiss Medtechs Count The Cost Of Being Without An MRA
Maintaining barrier-free trade with the EU will save time and money, according to the Swiss medtech industry, which has made its views clear in a recent survey run by Swiss Medtech.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.